Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SUMO2 anticorps (AbBy Fluor® 594)

L’anticorps Lapin Polyclonal anti-SUMO2 a été validé pour IF (p). Il convient pour détecter SUMO2 dans des échantillons de Humain, Rat et Souris.
N° du produit ABIN2806768

Aperçu rapide pour SUMO2 anticorps (AbBy Fluor® 594) (ABIN2806768)

Antigène

Voir toutes SUMO2 Anticorps
SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

Reactivité

  • 101
  • 39
  • 35
  • 3
  • 2
  • 1
  • 1
  • 1
Humain, Rat, Souris

Hôte

  • 79
  • 26
  • 1
Lapin

Clonalité

  • 80
  • 27
Polyclonal

Conjugué

  • 58
  • 9
  • 8
  • 7
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SUMO2 est conjugé à/à la AbBy Fluor® 594

Application

  • 71
  • 53
  • 38
  • 22
  • 14
  • 11
  • 10
  • 9
  • 6
  • 5
  • 4
  • 2
  • 1
  • 1
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human Sumo 2

    Isotype

    IgG
  • Indications d'application

    IF(IHC-P)(1:50-200)

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at 4°C

    Date de péremption

    12 months
  • Antigène

    SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

    Autre désignation

    Sumo 2

    Sujet

    The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, SUMO-2 and SUMO-3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2, and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, SUMO-2 and SUMO-3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include IkBa, MDM2, p53, PML and Ran GAP1. SUMO-2 and SUMO-3 contribute to a greater percentage of protein modification than does SUMO-1, and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates b-Amyloid generation and may be critical in the onset or progression of Alzheimer’s disease


    Synonyms: Small ubiquitin-related modier 2, SUMO-2, HSMT3, SMT3 homolog 2, SUMO-3, Sentrin-2, Ubiquitin-like protein SMT3A, Smt3A, SUMO2_HUMAN.

    ID gène

    6613

    Pathways

    Methionine Biosynthetic Process
Vous êtes ici:
Chat with us!